Cubist Systematic Strategies’s TScan Therapeutics TCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $250K | Buy |
172,512
+151,672
| +728% | +$220K | ﹤0.01% | 1177 |
|
2025
Q1 | $28.8K | Sell |
20,840
-42,255
| -67% | -$58.3K | ﹤0.01% | 1328 |
|
2024
Q4 | $192K | Buy |
63,095
+30,958
| +96% | +$94.1K | ﹤0.01% | 1187 |
|
2024
Q3 | $160K | Buy |
+32,137
| New | +$160K | ﹤0.01% | 1178 |
|
2024
Q2 | – | Sell |
-44,308
| Closed | -$352K | – | 2543 |
|
2024
Q1 | $352K | Buy |
44,308
+18,063
| +69% | +$143K | ﹤0.01% | 1493 |
|
2023
Q4 | $153K | Buy |
+26,245
| New | +$153K | ﹤0.01% | 1706 |
|